| Identification | Back Directory | [Name]
1H-Benzimidazole-1-ethanamine, N,N-diethyl-5-nitro-2-[(4-propoxyphenyl)methyl]- | [CAS]
95958-84-2 | [Synonyms]
FIubromazepa
FIubromazepam
Benzoimidazol-1-Yl]-Ethyl
1H-Benzimidazole-1-ethanamine, N,N-diethyl-5-nitro-2-[(4-propoxyphenyl)methyl]- | [Molecular Formula]
C23H30N4O3 | [MOL File]
95958-84-2.mol | [Molecular Weight]
410.51 |
| Chemical Properties | Back Directory | [InChI]
InChI=1S/C23H30N4O3/c1-4-15-30-20-10-7-18(8-11-20)16-23-24-21-17-19(27(28)29)9-12-22(21)26(23)14-13-25(5-2)6-3/h7-12,17H,4-6,13-16H2,1-3H3 | [InChIKey]
SJHUJFHOXYDSJY-UHFFFAOYSA-N | [SMILES]
C1(CC2=CC=C(OCCC)C=C2)N(CCN(CC)CC)C2=CC=C([N+]([O-])=O)C=C2N=1 |
| Hazard Information | Back Directory | [Description]
Protonitazene(95958-84-2) is a benzimidazole derivative with potent opioid effects which has been sold over the internet as a designer drug since around 2021, and has been identified in various European countries, as well as Canada, the USA and Australia. It has been linked to numerous cases of drug overdose, and is a Schedule I drug in the USA.
|
|
|